Clinical Trials Browser

Phase 2 × Ursodeoxycholic Acid × Breast × Clear all

NCT06842472 2025-02-24

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms